In biomedical scientific investigations, expositions of findings are conceptually simplest when they comprise comparisons of discrete groups of individuals or involve discrete features or characteristics of individuals. But the descriptive benefits of categorization become outweighed by their limitations in studies involving dose-response relationships, as in many teratogenic and environmental exposure studies. This article addresses a pair of categorization issues concerning the effects of prenatal alcohol exposure that have important public health consequences: the labeling of individuals as fetal alcohol syndrome (FAS) versus fetal alcohol effects (FAE) or alcoholrelated neurodevelopmental disorder (ARND), and the categorization of prenatal exposure dose by thresholds. We present data showing that patients with FAS and others with FAE do not have meaningfully different behavioral performance, standardized scores of IQ, arithmetic and adaptive behavior, or secondary disabilities. Similarly overlapping distributions on measures of executive functioning offer a basis for identifying alcohol-affected individuals in a manner that does not simply reflect IQ deficits. At the other end of the teratological continuum, we turn to the reporting of threshold effects in dose-response relationships. Here we illustrate the importance of multivariate analyses using data from the Seattle, Washington, longitudinal prospective study on alcohol and pregnancy. Relationships between many neurobehavioral outcomes and measures of prenatal alcohol exposure are monotone without threshold down to the lowest nonzero levels of exposure, a finding consistent with reports from animal studies. In sum, alcohol effects on the developing human brain appear to be a continuum without threshold when dose and behavioral effects are quantified appropriately.
In this article, we address a pair of categorization issues concerning the effects of prenatal alcohol exposure that have important public health consequences: the labeling of individuals as fetal alcohol syndrome (FAS) versus fetal alcohol effects (FAE) or alcohol-related neurodevelopmental disorder (ARND) , and the categorization of prenatal exposure dose by thresholds. The practice of classification or categorization is common in biological and medical scientific investigations. Expositions of findings are conceptually simplest when they comprise comparisons of discrete groups of individuals or involve discrete features or characteristics of individuals. Consider the broad range of investigations into human developmental disturbances and disabilities of known or perhaps uncertain origin. The case of Down syndrome provides a useful baseline for consideration. The genetic cause of the syndrome is discrete: you can have either two or three copies of chromosome 21, not, for example, 2.92 . And the consequences of the cause are also usefully considered discrete in the classification of individuals with the dysmorphologic and behavioral characteristics of the syndrome. While there is variation in the extent or magnitude of the morphologic and behavioral characteristics evidenced in the syndrome, all those with the genetic defect manifest these characteristics to a substantial extent, and the existence of the genetic defect can be reliably inferred from identification of these characteristics.
The benefits of categorization in terms of simple description become outweighed by limitations as one moves to studies involving dose-response relationships, as is the case in many teratogenic and environmental exposure studies. Issues arise in the measurement of the dose or cause of the developmental disturbance and also in the measurement of that disturbance. The benefits of categorization of response appear attractive: one can compare groups of people affected by exposure to certain levels of a teratogen to other groups of people not affected. And similarly, one may be able to discuss discrete levels of exposure that are necessary for effects to be manifest. There are obvious consequences of these categorizations for diagnostic practices, treatment, and public health policy. Furthermore, statistical analysis may be greatly simplified by these categorizations. Categorization may, for example, enable two-sample t-tests instead of possibly nonlinear dose-response regression analyses, or it may permit analysis in terms of contingency tables and risk of discrete events/effects. But categorization can be misleading, especially when a teratogenic cause must be measured in a multivariate manner to assess the timing and patterns of exposure and when the morphological and behavioral effects are subtle.
Our subject here is alcohol teratogenesis, for which the behavioral effects are sometimes subtle but nonetheless have major public health consequences in terms of secondary disabilities such as mental health problems, disrupted school experience, and trouble with the law. We begin with an assessment of the public health consequences of a misplaced emphasis on the categorization or diagnosis of FAS vis-a-vis other characterizations of fetal alcohol-affected individuals. We then discuss the issues of categorization of exposure and the reporting of threshold effects in dose-response relationships and conclude with a comment on the public health implications of the possible decision procedures.
Categorizing FAS and Screening for Prenatal Effects of Alcohol Background
An array of clinical manifestations was first described 25-30 years ago in young infants of three races born to chronically alcoholic mothers (1, 2) . Three broad categories of deficit emerged as the basis for a diagnosis of FAS: face, growth, and brain. Figure 1 depicts the characteristic face of FAS. Natural history studies reveal the increasing variability of the facial and growth characteristics with increasing age (4-10). These highlight the limited age range for using facial stigmata and even growth deficiency as criteria for the diagnosis of FAS. Since 1978, partial manifestations of these deficits have been described in offspring of alcoholic mothers. These have been termed fetal alcohol effects (FAE), a phrase sometimes preceded by "possible" or "probable" (11) (12) (13) , or mild FAS (Type III) (14, 15) . More recently, the Institute of Medicine of the U.S. National Academy of Sciences has suggested a new and extended system of classifications for children affected by prenatal alcohol exposure (16) . The classification alcohol-related neurodevelopmental disorder (ARND) essentially replaces the term FAE as used here to describe offspring with central nervous system (CNS) deficits but not all the physical features of FAS. Going from the level of the individual to the level of groups, epidemiologic studies examining the consequences of prenatal alcohol across the full range of exposures have revealed a broad spectrum of alcohol-related deficits in humans from birth through adolescence (17) (18) (19) (20) (21) (22) (23) (24) .
The teratogenicity of alcohol has been established by a vast experimental animal literature (25) (26) (27) (28) (7, 23, 38) , and a wide variety of behavioral problems (39) (40) (41) (42) . Figure 3 represents the combined FAS/FAE distributions for three of the most common types of psychological tests all scaled to a standard deviation of 15 (16) ]. Gestational alcohol exposure has particularly long-lasting effects on neurochemistry and neurophysiology. With exposure during the brain growth spurt (third trimester rodent models), many effects appear to be a linear function of the peak blood alcohol concentration attained. Further discussion and references for low-dose effects are provided in the Institute of Medicine report (16) .
CNS damage, occurring relatively early, when the developing brain is the most vulnerable, is understandably debilitating due to the inability of neurons to multiply or replace themselves after the initial production period (59) . Consuelo Guerri, in her discussion of the 1996 symposium cited above (53) , noted that, despite the great plasticity of the developing brain, it has limited repair capacity during development and therefore small disturbances in the correct formation of the different brain areas may result in behavioral deficits that may not be detected until school age or adulthood.
Proceeding to the literature on observational studies of humans, recent publications of Jacobson et al. (60) and Abel (61) would lead one to believe that issues of dose-response methodology have been oversimplified or neglected, as suggested also in the Institute of Medicine report. Jacobson et al. (60) state incorrectly that essentially all the prospective longitudinal studies of prenatal alcohol exposure have relied primarily on multiple regression or other correlational procedures that assume linear relationships between dose and effect and that will miss the effects of possible nonlinear or threshold effects in dose-response relationships. That is certainly not the case for most of the publications over the past 10 years from the Seattle longitudinal study (22, 62) , nor is it an accurate characterization of analyses reported by the Pittsburgh study (18) . Abel (61) These coefficient or salience vectors can be computed using an iterative algorithm derived from their implicit characterization as correlations as just described, or it can be shown that this characterization leads equivalently to their computation as the first pair of singular vectors of the m x n correlation matrix R between the dose and response scores. The latter suggests further interpretations of the saliences as explanations of the pattern of correlations between the measures of dose and response. For further discussion see Streissguth et al. (22) or Bookstein et al. (62) .
The calculation of saliences and latent variable scores must also recognize that our multiple alcohol measures arise on a variety of separate scales-ounces per day, counts of various sorts, categorizations of bingeing behavior, and simple dichotomies. For all of these except the last, conventional methods of nonlinear scaling apply to linearize the dose scale with respect to the composite outcome.
(We choose to rescale or linearize only the dose measures, not the neuropsychological outcomes.) This linearization is computed using now-common scatterplot smoothers nested within the iterative algorithm for the calculation of the saliences as correlations. Following this iterative calculation, one of the basic summaries of the analysis is then a simple scatterplot of the scores of the Alcohol and Outcome latent variables, LVx and LVy, as illustrated in Figure 5 based on the data presented in Sampson et al. (67) .
This approach is particularly useful for assessment of the form of the dose-response relation. The issue ofwhether there are meaningful thresholds requires consideration both of the scatterplot of latent variable scores illustrated in Figure 5 and of (smoothed) dose-response scatters for the composite latent variable outcome score against each of the single dose measures. The PLS LV is a combination of alcohol scores that is monotone increasing in each of its components and that is low or zero only when all components are low or zero. The group of subjects with low/zero scores on the alcohol LV is the most meaningful definition of a subgroup having no average alcohol-related deficits on the corresponding outcome LV. The definition of this group in terms of the nonlinear transformations of each of the individual alcohol components will be the basis of any conclusion about thresholds.
The PLS analysis underlying Figure 5 summarizes the relationship between 13 measures of prenatal alcohol exposure from maternal self-report and 25 outcome scores describing performance on three different cognitive tasks for 368 fourteen-year-old offspring of nonabstaining mothers (67) Alcohol LV Figure 5 . Scatterplot of scores on the first Latent Variable pair based on offspring of nonabstainers from Sampson et al. (67) . The Figure 6 shows plots of the estimated relationships of this most salient dose measure against the outcome LV for each of these, again based only on nonabstainers. The standard deviations of the outcome LV scores have been scaled to variance one for these plots. The transformations are largely consistent and three out of seven are monotone down to the smallest nonzero scores (ADOCCP = 1.5; see Figure 6 caption). The transforms for the average daily volume measures [see (22, 24, (66) (67) (68) (69) (70) Of greatest concern are the effects on brain development and function which include microcephaly, poor organization of brain, mental deficiency, behavioral aberration (especially hyperactivity) and neurological dysfunction (including "cerebral palsy"). (13) This challenge has gone unanswered until quite recently, not for lack of sympathy but because it can be considered only by eschewing the "face of FAS" as a diagnostic standard in favor of joint measurement or calibration of brain development and function. Tools for this task have been developed only in the late 1990s. What we learned while we were awaiting these tools is just how poor a guide to alcohol-related damage is the face of FAS. In the middle range of neurological deficits (i.e., those milder than frank mental retardation) patients diagnosed FAS are, as a group, little different from those diagnosed with fetal alcohol effects in terms of behavior. As Smith implied, what is needed first is an objective calibration of alcohol-related brain damage independent of the face. This goal can now be reached using new methods of multivariate neuroimage analysis and dose-response analysis. Only on the basis of this calibration can one properly assess the two principal issues addressed in this paper: the categorization of individuals, whether for the purpose of syndromology or for servicerelevant diagnosis, and the possible categorization of exposure in terms of meaningful thresholds based on dose-response analysis of alcohol-related damage. It is a practical necessity that we sort exposed individuals by the extent of alcohol-related deficits. Thereafter, arriving at a cut-point for a categorization of those of greatest deficits is essentially a social process determined by political and economic constraints.
While the FAS diagnosis indubitably signals the fact of alcohol damage, as a severity score it is essentially social, not neuronal. It is not the answer to a question about this scientific calibration. James Harris writes in a chapter on testing in developmental neuropsychiatry (71):
Developmental neuropsychiatric assessment requires the concurrent measurement of cognitive, emotional, social, and global adaptive functions. Because problems in each of these areas may arise from brain dysfunction, . . . neuropsychological testing integrates psychiatric and psychological information on behavior and the mind with neurological information on the brain (70) ; and 14-year cognitive processing (67) . These plots are based on analyses without the offspring of abstainers. The "loess" scatterplot smoother from Splus was applied to ADOCCP on a logarithmic scale for all the cases having scores greater than the minimum possible score, 1. (73) . Findings to date (in a study of adult males) indicate no meaningful differences in brain-behavior relationships for those with/without the face-those diagnosed FAS versus FAE-and no evidence of any threshold of particularly severe damage that might lead to some convenient qualification for social services. Instead, there may be clinically relevant subtypes of fetal alcohol damage independent of both the face and net severity.
The recent Institute of Medicine (16) report proposed a 5-fold categorization including two categories: a) "partial FAS with confirmed maternal alcohol exposure" and b) "alcohol-related neurodevelopmental disorder (ARND)," intended to apply to patients who show particular behavioral or cognitive abnormalities or delays (e.g., learning difficulties, or poor metacognition) that "cannot be explained by familial background or environment alone." We argue elsewhere (49) that it is not fruitful to attempt identification of characteristics "that cannot be explained by ... environment alone." The task of assessing that alternative explanation not only is more difficult than the teratogenic assignment but distracts from the task of explaining the brain damage. Instead, the behavioral and cognitive abnormalities to be scrutinized should be those found linked to the crucial intervening variable for any behavioral teratology study, viz, the trace of prenatal brain damage revealed in analyses of neuroanatomic or neurochemical structure (as by magnetic resonance imaging), neuropsychological performance or behavior, and prenatal alcohol exposure as best it can be assessed. The analytic strategies we have proposed calibrate explicitly and directly this link that connects the two components of the IOM specification of ARND: a) neurodevelopmental abnormalities, and b) behavior and cognitive abnormalities.
As argued above, the answer to the question of whether there are thresholds of exposure should be addressed taking note of biological mechanisms underlying threshold effects, carefully designed low-dose animal studies, and the most comprehensive (multivariate) calibration of alcohol-related brain damage in human studies. The latter provide our best representation of low-dose effects in humans. We do not claim that there is no threshold, but that on the basis of our data and plots like those in Figure 6 , there is no evidence of a threshold. The question of low-dose teratogenesis is separate from the issue of qualification for services, of course; it is an essentially statistical issue but of huge import for guidelines and warnings.
We agree with Smith's belief (13) in a continuum from unaffected through various manifestations of fetal alcohol effects, including FAS. We also agree with Harris (71) that it is the consequences for brain functioning, not any "lesion-like" effects, that organize the most effective investigations. The statistical summaries of the two studies that provided the data reported here confirm the wisdom of both these clinicians. The heterogeneity of the fetal alcohol domain is not usefully studied either by categorization or by thresholding; it requires sensitive attention to a great variety of patterns and rhythms of dose and to profiles of neuroanatomical and neurobehavioral deficit.
As Holmes (74) wrote, the severe end of the spectrum of alcohol effects has been overemphasized; he encouraged focusing on the more subtle effects of alcohol on the fetus, those that can result in behavioral problems and cognitive dysfunction. The methodology now exists for doing this in a multidimensional manner respecting the complexity of dose-response relationships that involve many dimensions of dose, many dimensions of developmental outcome, and many ages of development. Inappropriate categorizations in alcohol teratogenesis obscure our understanding of the underlying dose-response mechanisms, and of the rich range of outcomes. The unfortunate focus of attention on only the severe end of the spectrum of alcohol-related deficits has unnecessarily complicated the provision of needed services to those falling outside the narrow bands of eligibility designed for other types of disabilities.
